Publications by authors named "Natalia A Zhukova"

Article Synopsis
  • - Metabolic syndrome involves issues with glucose and lipid metabolism, requiring effective medication for treatment.
  • - Researchers created potential drugs that activate nuclear receptors PPAR-alpha and gamma to improve metabolism, utilizing a specific chemical structure derived from glitazars.
  • - In studies with obese mice suffering from type 2 diabetes, one drug effectively lowered triglycerides and blood sugar, while proving safe for the liver.
View Article and Find Full Text PDF

Researchers working in various domains are focusing on extracting information from data sets by data mining techniques. However, data mining is a complicated task, including multiple complex processes, so that it is unfriendly to non-computer researchers. Due to the lack of experience, they cannot design suitable workflows that lead to satisfactory results.

View Article and Find Full Text PDF

This article addresses the monitoring problem of the telecommunication networks. We consider these networks as multilevel dynamic objects. It shows that reconfigurable systems are necessary for their monitoring process in real life.

View Article and Find Full Text PDF

An experimental mouse model of dyslipidemia and atherosclerosis was utilized to study the generation of methylarginines in vivo, as well as any potential behavioral changes in mice associated with the production of excess methylarginines. Following 14 weeks of poloxamer 407 treatment, mice developed atherosclerosis and the plasma concentrations of monomethylarginine and asymmetric dimethylarginine were found to be significantly greater than corresponding concentrations in control mice. This finding may have contributed to the development of aortic atherosclerotic lesions in poloxamer-treated mice by interfering with nitric oxide availability and, hence, normal function of vascular endothelium.

View Article and Find Full Text PDF

Background: The aims of this study were to evaluate the effect of poloxamer 407 administration on atherogenic serum lipoprotein fractions and subfractions associated with cholesterol, triglycerides and phospholipids, as well as the onset of early atherosclerosis, in mice.

Methods: Mice were administered either sterile saline or poloxamer 407 (to induce a dose-controlled hyperlipidemia) for 1 month and then sacrificed at 1, 4 and 10 days after the last dose of poloxamer 407. Systolic and diastolic blood pressure, the activity of a cysteine protease (cathepsin B) in cardiac and liver tissue, and histological/morphological examination of heart and liver specimens was performed for each group of mice at each time point.

View Article and Find Full Text PDF

The effects of repeated administration of poloxamer 407 (P-407) on lipoprotein-cholesterol (LP-C) and lipoprotein-triglyceride (LP-TG) fractions and subfractions, as well as the effect on liver and heart proteases, were studied. Repeated administration of P-407 to male CBA mice resulted in a model of atherosclerosis with increased diastolic blood pressure; there was a drastic increase in total serum cholesterol and especially TG. A novel small-angle X-ray scattering method for the determination of the fractional and subfractional composition of LP-C and LP-TG was used.

View Article and Find Full Text PDF